Whenever the Thai government defiesforeign drug patents and creates its own cheap copies of drugs, it endangers the patients who need the drugs and undermines drug discovery.

As Thailand overrides patents on foreign drugs, the only winner will be the government.

Innovation by India's internationally competitive scientists suffersfrom the Indian government'sprotectionist policies.

Counterfeit and substandard pharmaceuticals are a massive problem, and international bodies need to confront them head-on.

The Thai government is breaking patents on Western drugs, but such actionwill haveconsequences for theThailand,afflicted patients, and global health.

Production of pharmaceuticals in developing countries can promote growth--but only when the market prescribes it.

Despite all of the regulatory baggage being heaped on the large drug makers in Washington, their biggest drags may be inside their own laboratories.

Help for medicinal innovation in Thailand is coming from an unlikely source.